Regenerx Biopharmaceuticals Inc (RGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 77 | 77 | 77 | 77 | 70 |
| Gross Profit | 77 | 77 | 77 | 77 | 70 |
| Operating Expenses | 1,479 | 1,405 | 1,371 | 1,339 | 1,393 |
| Operating Income | -1,402 | -1,329 | -1,295 | -1,262 | -1,323 |
| Interest Expense | 326 | 325 | 233 | 153 | 87 |
| Other Income | 0 | 56 | 4 | 11 | -583 |
| Pre-tax Income | -1,728 | -1,598 | -1,523 | -1,404 | -1,994 |
| Net Income Continuous | -1,728 | -1,598 | -1,523 | -1,404 | -1,994 |
| Net Income | $-1,728 | $-1,598 | $-1,523 | $-1,404 | $-1,994 |
| EPS Basic Total Ops | -1.00 | -1.00 | -1.00 | -1.00 | -2.00 |
| EPS Basic Continuous Ops | -1.20 | -1.15 | -1.14 | -1.07 | -1.65 |
| EPS Diluted Total Ops | -1.00 | -1.00 | -1.00 | -1.00 | -2.00 |
| EPS Diluted Continuous Ops | -1.20 | -1.15 | -1.14 | -1.07 | -1.65 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | N/A | N/A | -2.00 |
| EBITDA(a) | $-1,402 | $-1,329 | $-1,295 | $-1,261 | $-1,321 |